4//SEC Filing
Svoronos Dawn 4
Accession 0001415889-25-017850
CIK 0001501756other
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 4:24 PM ET
Size
5.7 KB
Accession
0001415889-25-017850
Insider Transaction Report
Form 4
Graham Dawn
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-17+10,450→ 10,450 totalExercise: $2.32Exp: 2035-06-16→ Common Stock (10,450 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest and become exercisable on the earlier of June 17, 2026 or the 2026 annual meeting of stockholders, subject to (1) accelerated vesting upon a change of control and (2) the Reporting Person's continued service with the Issuer on the vesting date.
Documents
Issuer
Adverum Biotechnologies, Inc.
CIK 0001501756
Entity typeother
Related Parties
1- filerCIK 0001574579
Filing Metadata
- Form type
- 4
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 4:24 PM ET
- Size
- 5.7 KB